Science AdvancesBioinformaticsPeer-reviewed journal article
Biologically relevant integration of transcriptomics profiles from cancer cell lines, patient-derived xenografts and clinical tumors using deep learning
Slavica DimitrievaiD, Rens JanssensiD, Gang LiiD, Artur SzałataiD, Rajaraman GopalakrishnaniD, Chintan ParmariD, Audrey KauffmanniD, Eric Y. Durand
Abstract
Cell lines and patient-derived xenografts are essential to cancer research, however, the results derived from such models often lack clinical translatability, as these models do not fully recapitulate the complex cancer biology. It is critically important to better understand the systematic differences between cell lines, xenografts and clinical tumors, and to be able to identify pre-clinical models that sufficiently resemble the biological characteristics of clinical tumors across different cancers. On another side, direct comparison of transcriptional profiles from pre-clinical models and clinical tumors is infeasible due to the mixture of technical artifacts and inherent biological signals. To address these challenges, we developed MOBER, Multi-Origin Batch Effect Remover method, to simultaneously extract biologically meaningful embeddings and remove batch effects from transcriptomic datasets of different origin. MOBER consists of two neural networks: conditional variational autoencoder and source discriminator neural network that is trained in adversarial fashion. We applied MOBER on transcriptional profiles from 932 cancer cell lines, 434 patient-derived tumor xenografts and 11159 clinical tumors and identified pre-clinical models with greatest transcriptional fidelity to clinical tumors, and models that are transcriptionally unrepresentative of their respective clinical tumors. MOBER can conserve the biological signals from the original datasets, while generating embeddings that do not encode confounder information. In addition, it allows for transformation of transcriptional profiles of pre-clinical models to resemble the ones of clinical tumors, and therefore can be used to improve the clinical translation of insights gained from pre-clinical models. As a batch effect removal method, MOBER can be applied widely to transcriptomics datasets of different origin, allowing for integration of multiple datasets simultaneously.
- organism: human
- assay: bulk RNA-seq
- research focus: batch correction / integration
- research focus: dimensionality reduction
- research focus: benchmarking
- approach: deep learning
- approach: variational autoencoder
- approach: contrastive learning
- Citations
- 5
- FWCI
- 1.49
- Field percentile
- top 21%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Integration of proteomic data from cell lines and tumors
Cong Quan Ta, Johannes Maria Auth, … Andreas Raue·bioRxiv·Aug 24, 2026
- Global computational alignment of tumor and cell line transcriptional profiles
A. Warren, A. Jones, … J. M. McFarland·bioRxiv·Mar 25, 2020
- Comprehensive transcriptomic analysis of cell lines as models of primary tumor samples across 22 tumor types
Katharine Yu, Bin Chen, … Marina Sirota·Nature CommunicationsPeer-reviewed·Aug 8, 2019
- Multi-task deep latent spaces for cancer survival and treatment response prediction
Teemu Rintala, Francesco Napolitano, Vittorio Fortino·BioinformaticsPeer-reviewed·Jun 17, 2024
- Identifying commonalities between cell lines and tumors at the single cell level using Sobolev Alignment of deep generative models
Soufiane M. C. Mourragui, Joseph C. Siefert, … Lodewyk F.A. Wessels·bioRxiv·Mar 8, 2022
- Evaluating cancer cell line and patient-derived xenograft recapitulation of tumor and non-diseasedtissue gene expression profiles in silico
Avery S. Williams, Elizabeth J. Wilk, … Brittany N. Lasseigne·Cancer ReportsPeer-reviewed·Aug 2, 2023